The main strength of the present study is the use of a genetic instrument to determine the causal effects of common variation in MC4R on cardiovascular disease risk, using data from several large cohort studies, including the CCHS/CGPS and UK Biobank. This evidence concerns the gene MC4R and cardiovascular disorder.